These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30809524)

  • 1.
    Crawford T; Fletcher N; Veitch M; Gonzalez Cruz JL; Pett N; Brereton I; Wells JW; Mobli M; Tesiram Y
    Front Med (Lausanne); 2019; 6():22. PubMed ID: 30809524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthrax Toxin Protective Antigen Variants That Selectively Utilize either the CMG2 or TEM8 Receptors for Cellular Uptake and Tumor Targeting.
    Chen KH; Liu S; Leysath CE; Miller-Randolph S; Zhang Y; Fattah R; Bugge TH; Leppla SH
    J Biol Chem; 2016 Oct; 291(42):22021-22029. PubMed ID: 27555325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells.
    Chen KH; Liu S; Bankston LA; Liddington RC; Leppla SH
    J Biol Chem; 2007 Mar; 282(13):9834-9845. PubMed ID: 17251181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capillary morphogenesis gene 2 (CMG2) mediates growth factor-induced angiogenesis by regulating endothelial cell chemotaxis.
    Cryan LM; Tsang TM; Stiles J; Bazinet L; Lee SL; Garrard S; Madrian E; Roberts C; Payne J; Jensen A; Frankel AE; Ackroyd PC; Christensen KA; Rogers MS
    Angiogenesis; 2022 Aug; 25(3):397-410. PubMed ID: 35212873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.
    Scobie HM; Rainey GJ; Bradley KA; Young JA
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5170-4. PubMed ID: 12700348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-enhanced immunogenicity of anthrax protective antigen is primarily mediated by capillary morphogenesis Protein-2.
    Verma A; Moayeri M; Mocca CP; O'Mard D; Ma Q; Leppla SH; Burns DL
    Vaccine; 2022 Jul; 40(32):4318-4321. PubMed ID: 35710508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen.
    Wigelsworth DJ; Krantz BA; Christensen KA; Lacy DB; Juris SJ; Collier RJ
    J Biol Chem; 2004 May; 279(22):23349-56. PubMed ID: 15044490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-specific requirements for anthrax toxin delivery into cells.
    Rainey GJ; Wigelsworth DJ; Ryan PL; Scobie HM; Collier RJ; Young JA
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13278-83. PubMed ID: 16141341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A FRET-based high throughput screening assay to identify inhibitors of anthrax protective antigen binding to capillary morphogenesis gene 2 protein.
    Rogers MS; Cryan LM; Habeshian KA; Bazinet L; Caldwell TP; Ackroyd PC; Christensen KA
    PLoS One; 2012; 7(6):e39911. PubMed ID: 22768167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of small molecules that inhibit the interaction of TEM8 with anthrax protective antigen using a FRET assay.
    Cryan LM; Habeshian KA; Caldwell TP; Morris MT; Ackroyd PC; Christensen KA; Rogers MS
    J Biomol Screen; 2013 Jul; 18(6):714-25. PubMed ID: 23479355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution.
    Rouleau C; Menon K; Boutin P; Guyre C; Yoshida H; Kataoka S; Perricone M; Shankara S; Frankel AE; Duesbery NS; Vande Woude G; Biemann HP; Teicher BA
    Int J Oncol; 2008 Apr; 32(4):739-48. PubMed ID: 18360701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of anthrax protective antigen outside and inside the cell.
    Backer MV; Patel V; Jehning BT; Claffey KP; Karginov VA; Backer JM
    Antimicrob Agents Chemother; 2007 Jan; 51(1):245-51. PubMed ID: 17074791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between anthrax toxin receptors and protective antigen.
    Scobie HM; Young JA
    Curr Opin Microbiol; 2005 Feb; 8(1):106-12. PubMed ID: 15694864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor endothelial marker 8 amplifies canonical Wnt signaling in blood vessels.
    Verma K; Gu J; Werner E
    PLoS One; 2011; 6(8):e22334. PubMed ID: 21829615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant HSA-CMG2 Is a Promising Anthrax Toxin Inhibitor.
    Li L; Guo Q; Liu J; Zhang J; Yin Y; Dong D; Fu L; Xu J; Chen W
    Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26805881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of domain 4 of the anthrax toxin protective antigen and the effect of the VWA domain of CMG2 on stability.
    Mamillapalli S; Miyagi M; Bann JG
    Protein Sci; 2017 Feb; 26(2):355-364. PubMed ID: 27874231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the pathogenesis of anthrax infection.
    Bonuccelli G; Sotgia F; Frank PG; Williams TM; de Almeida CJ; Tanowitz HB; Scherer PE; Hotchkiss KA; Terman BI; Rollman B; Alileche A; Brojatsch J; Lisanti MP
    Am J Physiol Cell Physiol; 2005 Jun; 288(6):C1402-10. PubMed ID: 15689409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth.
    Rogers MS; Christensen KA; Birsner AE; Short SM; Wigelsworth DJ; Collier RJ; D'Amato RJ
    Cancer Res; 2007 Oct; 67(20):9980-5. PubMed ID: 17942931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor.
    Lacy DB; Wigelsworth DJ; Scobie HM; Young JA; Collier RJ
    Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6367-72. PubMed ID: 15079089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CMG2 ELISA for evaluating inhibitors of the binding of anthrax toxin protective antigen to its receptor.
    Dawson RM
    J Pharmacol Toxicol Methods; 2009; 59(1):50-5. PubMed ID: 19049885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.